03:06:36 EDT Thu 13 Jun 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Diagnos Inc (3)
Symbol ADK
Shares Issued 75,684,300
Close 2024-04-02 C$ 0.32
Market Cap C$ 24,218,976
Recent Sedar Documents

Diagnos grants Couillard option to buy 250,000 shares

2024-04-03 14:31 ET - News Release

Mr. Andre Larente reports

DIAGNOS ANNOUNCES GRANT OF STOCK OPTIONS

Diagnos Inc. has granted 250,000 stock options to one of its directors, Philippe Couillard.

Stock options vest at 50 per cent per year, commencing with the first anniversary of the grant. The exercise price of the stock options has been established at 32 cents per common share. The date of the grant is April 3, 2024. The stock options can be exercised up to April 3, 2029.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modification and development of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.